NEWS

May 19, 2025

REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million

March 18, 2025

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

March 13, 2025

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty

January 30, 2025

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan

December 18, 2024

Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions

September 11, 2024

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement

August 6, 2024

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics

July 23, 2024

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

July 22, 2024

Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®

July 18, 2024

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments